Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Fischinger

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
ACS Central Science|May 30, 2023
Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2Michael G Wuo, Amanda E Dugan, Melanie Halim, et al.
The Journal of Applied Laboratory Medicine|July 1, 2021
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Immunity|January 29, 2022
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernPaulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, et al.
Cell|November 18, 2020
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityTomer Zohar, Carolin Loos, Stephanie Fischinger, et al.
Plos Biology|February 10, 2022
SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohortEmilie Finch, Rachel Lowe, Stephanie Fischinger, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profilesPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Ebiomedicine|June 28, 2023
IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold minersLeela R L Davies, Malisa T Smith, Deniz Cizmeci, et al.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Nature|November 7, 2018
Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeysErica N Borducchi, Jinyan Liu, Joseph P Nkolola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2022
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIVEdgar T Overton, Isabelle R Weir, Markella V Zanni, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
ACS Central Science|May 30, 2023
Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2Michael G Wuo, Amanda E Dugan, Melanie Halim, et al.
The Journal of Applied Laboratory Medicine|July 1, 2021
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Immunity|January 29, 2022
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernPaulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, et al.
Cell|November 18, 2020
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityTomer Zohar, Carolin Loos, Stephanie Fischinger, et al.
Plos Biology|February 10, 2022
SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohortEmilie Finch, Rachel Lowe, Stephanie Fischinger, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profilesPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Ebiomedicine|June 28, 2023
IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold minersLeela R L Davies, Malisa T Smith, Deniz Cizmeci, et al.
Science Translational Medicine|March 29, 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functionsPaulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Nature|November 7, 2018
Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeysErica N Borducchi, Jinyan Liu, Joseph P Nkolola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2022
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIVEdgar T Overton, Isabelle R Weir, Markella V Zanni, et al.
Pageof 8